NCT07313891 2026-03-17
BOOST
Relmada Therapeutics, Inc.
Phase 3 Withdrawn
Clinical Trials
7 trialsNCT07342517 2026-03-17
RESCUE
Relmada Therapeutics, Inc.
Phase 3 Withdrawn
NCT04630483 2022-05-04
Platelet-lymphocyte and Neutrophil-lymphocyte Ratio in Patients Undergoing Cancer Surgery
Medipol University
Withdrawn
NCT02915172 2017-06-26
Lenvatinib and Capecitabine in Patients With Advanced Malignancies
M.D. Anderson Cancer Center
Phase 1 Withdrawn
NCT02108587 2016-10-20
Optical Coherence Tomography in Staging Patients With Upper Tract Urothelial Cancer
Case Comprehensive Cancer Center
Phase NA Withdrawn
NCT01799499 2015-09-01
NMIBC TURBT HG
UroGen Pharma Ltd.
Phase NA Withdrawn
NCT02254915 2015-04-01
SHTC-EUROPE-1
Medical Enterprises Europe B.V.
Phase 3 Withdrawn